Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairment and Insulin Resistance

NCT07220694 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

140

Enrollment

NETWORK

Sponsor class

Conditions

Insulin Resistance
Mild Cognitive Impairment
Cognitive Decline
Neurodegenerative Disorders

Interventions

DIETARY_SUPPLEMENT: Sabroxy®
OTHER: Placebo

Sponsor

SF Research Institute, Inc.

Collaborators

[object Object]